Global vaccine alliance Gavi has announced a $1bn package to support African vaccine manufacturers, a move expected to boost JSE-listen Aspen Pharmacare and state-backed Biovac.

Gavi’s decision to create the African Vaccine Manufacturing Accelerator (AVMA) is the culmination of a long-running campaign by the AU to reduce the risk of member nations being last in line when jabs are in short supply, as they were during the Covid-19 pandemic...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.